Award
National Cancer Institute 1R01CA309039-01
Genome-Wide In Vivo CRISPR Screens in Human T Cells Identify GPCR Pathway Targets to Enhance CAR-T Therapies for Solid Tumors
Recipient
National Cancer Institute (NCI), part of the NIH
Award Amount
$680,597.00
Ceiling
$680,597.00
Awarded
March 25, 2026
Identifier
1R01CA309039-01
Award for research on genome-wide CRISPR screens in human T cells to improve CAR-T therapies for solid tumors, funded by NIH/NCI with $680,597.
Description
This project involves genome-wide CRISPR screening in human T cells to identify GPCR pathway targets for enhancing CAR-T therapies against solid tumors. The award is funded by the NIH/NCI with a total amount of approximately $680,597 for the fiscal year 2026. The project aims to develop more effective T cell therapies and establish new standards for in vivo functional genomics screens.